Clinical course and outcomes of methamphetamine-dependent adults with psychosis

Journal of Substance Abuse Treatment

Volumn 35, Issue 4, 2008, Pages 445-450

  Glasner Edwards, Suzette ^a   Mooney, Larissa J ^a   Marinelli Casey, Patricia ^a   Hillhouse, Maureen ^a   Ang, Alfonso ^a   Rawson, Richard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Comorbidity; Methamphetamine; Psychosis; Treatment outcome

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; FOLLOW UP; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSYCHOSIS; SOCIAL PSYCHOLOGY;

ADULT; AMPHETAMINE-RELATED DISORDERS; CENTRAL NERVOUS SYSTEM STIMULANTS; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL HEALTH SERVICES; METHAMPHETAMINE; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 54249119239     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2007.12.004     Document Type: Article

References (31)

1. Bartels S.J., Teague G.B., Drake R.E., Clark R.E., Bush P.W., and Noordsy D.L. Substance abuse in schizophrenia: Service utilization and costs. Journal of Nervous and Mental Disease 181 (1993) 227-232
2. Carroll K.M., Power M.E., Bryant K., and Rounsaville B.J. One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. Journal of Nervous and Mental Disease 181 (1993) 71-79
3. Chen C.K., Lin S.K., Sham P.C., Ball D., Loh E.W., Hsiao C.C., et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychologica Medicine 33 (2003) 1407-1414
4. Chen C.K., Lin S.K., Sham P.C., Ball D., Loh E.W., and Murray R.M. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet B Neuropsychiatr Genet 136 (2005) 87-91
5. Curran C., Byrappa N., and McBride A. Stimulant psychosis: Systematic review. British Journal of Psychiatry 185 (2004) 196-204
6. Dalmau A., Bergman B., and Brismar B. Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness. European Psychiatry 14 (1999) 366-371
7. Derogatis L.R., and Melisaratos N. The Brief Symptom Inventory: An introductory report. Psychologica Medicine 13 (1983) 595-605
8. Drake R.E., Mueser K.T., Clark R.E., and Wallach M.A. The course, treatment, and outcome of substance disorder in persons with severe mental illness. American Journal of Orthopsychiatry 66 (1996) 42-51
9. Hillhouse M., Marinelli-Casey P., and Rawson R. The LET (Life Experience Timeline): A new instrument for collecting time-anchored natural history data. Poster Presented at the 67th annual meeting of the College on Problems of Drug Dependence, Orlando, Florida (2005)
10. Hunter E.E., Powell B.J., Penick E.C., Nickel E.J., Liskow B.I., Cantrell P.J., et al. Comorbid psychiatric diagnosis and long-term drinking outcome. Comprehensive Psychiatry 41 (2000) 334-338
11. Iwanami A., Sugiyama A., Kuroki N., Toda S., Kato N., Nakatani Y., et al. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report. Acta Psychiatrica Scandinavica 89 (1994) 428-432
12. Landheim A.S., Bakken K., and Vaglum P. Impact of comorbid psychiatric disorders on the outcome of substance abusers: A six year prospective follow-up in two Norwegian counties. BMC Psychiatry 6 (2006) 44
13. McKay J.R., Alterman A.I., Cacciola J.S., Mulvaney F.D., and O'Brien C.P. Prognostic significance of antisocial personality disorder in cocaine-dependent patients entering continuing care. Journal of Nervous and Mental Disease 188 (2000) 287-296
14. McKetin R., McLaren J., Lubman D.I., and Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 101 (2006) 1473-1478
15. McLellan A.T., Woody G.E., and O'Brien C.P. Development of psychiatric disorders in drug abusers. New England Journal of Medicine 301 (1979) 1310-1314
16. McLellan A.T., Luborsky L., Woody G.E., and O'Brien C.P. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. Journal of Nervous and Mental Disease 168 (1980) 26-33
17. McNamara C., Schumacher J.E., Milby J.B., Wallace D., and Usdan S. Prevalence of nonpsychotic mental disorders does not affect treatment outcome in a homeless cocaine-dependent sample. American Journal of Drug and Alcohol Abuse 27 (2001) 91-106
18. Nurco D.N., Bonito A.J., Lerner M., and Balter M.B. Studying addicts over time: Methodology and preliminary findings. American Journal of Drug and Alcohol Abuse 2 (1975) 183-196
19. Rawson R., Huber A., Brethen P., Obert J., Gulati V., Shoptaw S., et al. Methamphetamine and cocaine users: Differences in characteristics and treatment retention. Journal of Psychoactive Drugs 32 (2000) 233-238
20. Rawson R.A., Marinelli-Casey P., Anglin M.D., Dickow A., Frazier Y., Gallagher C., et al. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 99 (2004) 708-717
21. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264 (1990) 2511-2518
22. Ritsher J.B., McKellar J.D., Finney J.W., Otilingam P.G., and Moos R.H. Psychiatric comorbidity, continuing care and mutual help as predictors of five-year remission from substance use disorders. Journal of Studies on Alcohol 63 (2002) 709-715
23. Rounsaville B.J., Anton S.F., Carroll K., Budde D., Prusoff B.A., and Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Archives of General Psychiatry 48 (1991) 43-51
24. Rounsaville B.J., Dolinsky Z.S., Babor T.F., and Meyer R.E. Psychopathology as a predictor of treatment outcome in alcoholics. Archives of General Psychiatry 44 (1987) 505-513
25. Sato M. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Annals of the New York Academy of Sciences 654 (1992) 160-170
26. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59 Suppl 20 (1998) 22-33 (quiz 34-57)
27. Shoptaw S., Peck J., Reback C.J., and Rotheram-Fuller E. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment. Journal of Psychoactive Drugs 35 Suppl 1 (2003) 161-168
28. Swofford C.D., Kasckow J.W., Scheller-Gilkey G., and Inderbitzin L.B. Substance use: A powerful predictor of relapse in schizophrenia. Schizophrenia Research 20 (1996) 145-151
29. Yui K., Ikemoto S., Ishiguro T., and Goto K. Studies of amphetamine or methamphetamine psychosis in Japan: Relation of methamphetamine psychosis to schizophrenia. Annals of the New York Academy of Sciences 914 (2000) 1-12
30. Ziedonis D., Steinberg M.L., Smelson D., and Wyatt S. Co-occurring addictive and psychotic disorders. In: Graham A.W., Schultz T.K., Mayo-Smith M.F., Ries R.K., and Wilford B.B. (Eds). Principles of Addiction Medicine. 3rd ed (2003), American Society of Addiction Medicine, Inc, Maryland 1297-1319
31. Zweben J.E., Cohen J.B., Christian D., Galloway G.P., Salinardi M., Parent D., et al. Psychiatric symptoms in methamphetamine users. American Journal on Addictions 13 (2004) 181-190